Health Care/Life Science Analysts

Senior Research Analyst
Biotechnology

Chris Raymond is Baird’s senior analyst covering Biotechnology. Prior to joining Baird in 2002, he was a biotech analyst at Prudential and Prudential Vector Healthcare Group. Previously, he spent 10 years with Baxter Healthcare and G.D. Searle, where he focused on marketing oncology and cellular therapy products. In 2004, Chris was named among the “Best on the Street” in The Wall Street Journal’s annual analyst survey, ranking among the top three analysts in the Biotechnology category. Chris currently serves on the advisory board for the Financial Markets Institute at the Eli Broad College of Business, Michigan State University. Chris received a BA from Michigan State University and an MBA from the University of Chicago.

Senior Research Analyst
Biotechnology

Tom is a Baird senior analyst covering Biotechnology. Prior to joining Baird in 2004, he spent nine years with Merck & Co. Inc., where his operations roles spanned both biologics and traditional pharmaceutical products. Tom received a BS from the University of Notre Dame in Biological Sciences and an MBA with concentrations in Finance and Accounting from the University of Chicago.

Senior Research Analyst
Facilities & Services

Whit is Baird’s senior analyst covering Health Care Facilities & Services. Prior to joining Baird in 2008, he was a senior analyst at Stephens Inc. covering Healthcare Facilities & Services, specifically acute care hospitals, behavioral hospitals, alternate site and post-acute providers as well as Healthcare IT.  Prior to joining Stephens Inc., Whit was an investment analyst at Reliance Trust.  He received a BA in economics from The University of the South (Sewanee).

Senior Research Analyst
Health Care Distribution & Services

Eric is Baird’s senior analyst covering Health Care Distribution & Services. Prior to joining Baird in 2003, he was a senior analyst in pharmaceutical and biotechnology services at Prudential Securities, a senior analyst in life sciences at Wachovia Securities and an investment analyst at Morehead Investment Advisors. In 2006 and 2007, he was recognized among the The Wall Street Journal’s “Best on the Street” listing in the Health-Care Providers sector. In both 2007 and 2008, he was ranked by StarMine as a Top 3 Industry Estimator and Stock Picker in the Life Sciences Tools & Services Industry. Eric received a BA in Political Science from Wake Forest University, and an MBA with a concentration in Finance from Queens University.

Senior Research Analyst
Life Sciences & Diagnostics

Quintin is Baird’s senior analyst covering Life Sciences & Diagnostics. Prior to joining Baird in 2002, he was a senior research and production engineer with Atlantic Richfield, at ARCO’s research and development center and at ARCO Alaska. In 2007, Quintin was recognized among the "Best on the Street" by The Wall Street Journal, ranking among the top five analysts in the Medical Equipment & Supplies sector. In the 2006 Forbes.com/StarMine Analyst Awards, he ranked No. 1 for his stock-picking skills in Healthcare Equipment and Supplies. Quintin received a BS in Chemical Engineering from the University of Alabama, an MBA with a concentration in Finance and Accounting from the University of Chicago, and a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison.

Senior Research Analyst
Medical Technology

Jeff is Baird’s senior analyst covering Medical Technology. Prior to joining Baird in 2003, he was an optometrist and the associate director of Refractive Surgery Services at the Massachusetts Eye and Ear Infirmary. He was also an instructor of ophthalmology at Harvard Medical School, an adjunct assistant professor of optometry at the New England College of Optometry and an equity research intern at Baird. Jeffrey received his MBA from Northwestern University, graduated summa cum laude and as salutatorian from the Illinois College of Optometry, and did his undergraduate work at the University of Illinois-Urbana-Champaign.

Senior Research Analyst
Specialty Pharmaceuticals

Larry is Baird’s senior analyst covering Specialty Pharmaceuticals. Prior to joining Baird in 1989, he spent several years at Blunt, Ellis & Loewi, where he followed companies in the medical device and products businesses. In addition to his duties at Baird, Larry is also a member of the Scientific Advisory Board of the Medical College of Wisconsin. He received a BA from Lawrence University and an MBA from the University of Chicago.